In honor of Heart Month, it’s essential to address the impact of arterial stiffness and high blood pressure on cardiovascular health. Vitamin K2, especially MenaQ7®, helps improve arterial elasticity and blood flow, promoting better heart health.
As we age, a harmful cycle of increasing arterial stiffness and rising blood pressure can place significant strain on the heart and increase the risk of cardiovascular diseases. Arterial stiffness leads to higher blood pressure, which in turn causes more stress on the heart, perpetuating the cycle. Breaking this pattern is essential for maintaining vascular health, and one effective way to do so is by improving arterial elasticity, which helps regulate blood pressure and reduce cardiovascular risks.
Vitamin K2 is crucial in supporting arterial health by improving several key parameters. It activates Matrix GLA Protein (MGP), a potent inhibitor of vascular calcification, which helps maintain arterial elasticity. Additionally, vitamin K2 reduces oxidative stress and inflammation, two factors that accelerate the aging process of the vascular system. By enhancing endothelial function, vitamin K2 also helps blood vessels regulate blood flow, maintain stable blood pressure, and prevent clotting, contributing to overall cardiovascular wellness.
Clinical studies on MenaQ7® (180 μg/day) highlight its significant impact on vascular health. In postmenopausal women, MenaQ7® was shown to reduce arterial stiffness and activate MGP, improving arterial elasticity. It also enhanced arterial elasticity in adults with low vitamin K status, showing benefits in a short period. Furthermore, MenaQ7® has been proven to reduce blood pressure and improve arterial elasticity in women with high baseline stiffness. Given these findings, MenaQ7® is an effective option for supporting healthy blood pressure and improving cardiovascular health, especially for those with compromised arterial elasticity or low vitamin K levels.
Download the new brochure about MenaQ7® & blood pressure to know more.